Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Delayed Nasdaq
Other stock markets
 19:17:23 17/07/2024 BST 		5-day change 1st Jan Change
0.5724 USD +0.42% Intraday chart for Galecto, Inc. +14.25% -20.50%
06-10 Oppenheimer Adjusts Price Target on Galecto to $9 From $10, Maintains Outperform Rating MT
05-01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI
3a0726c3.59gdxxhF3HXx1ncT4ldDEURbRZ7myHiQzWvcZ9EgplQ.lexklmoHlQ2g5Bl-mm93aRsUDu-AgzvIozuDP7xiz2O1gHGIWXGVJqC3Rw~d29ead499039766a5b3667782017b53a
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. News Chart